Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Launchpad Therapeutics
company
About
Launchpad Therapeutics operates as an antibody-focused precision oncology company.
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $30M
- Industries
- Life Science,Therapeutics
- Founded date
- Jan 1, 2022
- Operating Status
- Active
Launchpad Therapeutics operates as an antibody-focused precision oncology company.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$30M
Launchpad Therapeutics has raised a total of
$30M
in funding over 2 rounds. Their latest funding was raised on
Dec 12, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 12, 2022 | Series A | $30M | 2 |
Versant Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Launchpad Therapeutics is funded by 2 investors.
Versant Ventures
and Black Diamond Therapeutics
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
Yes | Series A |
Black Diamond Therapeutics
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
